Cargando…

Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE)

INTRODUCTION: The objective of this analysis was to describe in real-life settings the clinical outcomes and safety associated with daptomycin treatment in a cohort of patients with complicated skin and soft tissues infection (cSSTI). METHODS: All patients with cSSTI who had received at least one do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cogo, Alberto, Gonzalez-Ruiz, Armando, Pathan, Rashidkhan, Hamed, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575295/ https://www.ncbi.nlm.nih.gov/pubmed/26168987 http://dx.doi.org/10.1007/s40121-015-0074-x

Ejemplares similares

Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE)
por: Guleri, Achyut, et al.
Publicado: (2015)

Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE
por: Seaton, R. Andrew, et al.
Publicado: (2016)

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2015)

Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE)
por: Lübbert, Christoph, et al.
Publicado: (2015)

Daptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry
por: Keil, Felix, et al.
Publicado: (2015)

Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience
por: Seaton, R. Andrew, et al.
Publicado: (2015)

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database
por: Seaton, R. Andrew, et al.
Publicado: (2013)

Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents
por: Syriopoulou, Vassiliki, et al.
Publicado: (2016)

Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry
por: Malizos, K., et al.
Publicado: (2015)

Brazilian experience in EU-CORE: daptomycin registry and treatment of serious Gram-positive infections
por: Timerman, Artur, et al.
Publicado: (2013)

Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin
por: White, Beth, et al.
Publicado: (2011)

Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2016)

Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin
por: Eckmann, Christian, et al.
Publicado: (2010)

Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections
por: Aikawa, Naoki, et al.
Publicado: (2012)

The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infections
por: Szczypinska, Ewa, et al.
Publicado: (2013)

A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections
por: Shoemaker, D Matthew, et al.
Publicado: (2006)

Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis
por: Liu, Chao, et al.
Publicado: (2016)

Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet)
por: Brandenburg, Vincent, et al.
Publicado: (2015)

Pharmacokinetics and skin-tissue penetration of daptomycin in rats
por: Matsumoto, Kazuaki, et al.
Publicado: (2015)

Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
por: Stephens, Jennifer M, et al.
Publicado: (2013)

Comparative Efficacy and Safety of Vancomycin, Linezolid, Tedizolid, and Daptomycin in Treating Patients with Suspected or Proven Complicated Skin and Soft Tissue Infections: An Updated Network Meta-Analysis
por: Feng, Jingjuan, et al.
Publicado: (2021)

The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials
por: Wang, Shou Zhen, et al.
Publicado: (2014)

In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid
por: Vanegas Múnera, Johanna Marcela, et al.
Publicado: (2017)

Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry
por: Martone, W J, et al.
Publicado: (2008)

Daptomycin: Local Application in Implant-Associated Infection and Complicated Osteomyelitis
por: Rosslenbroich, Steffen B., et al.
Publicado: (2012)

Acute Eosinophilic Pneumonia: A Rare Complication of Daptomycin Therapy
por: Storandt, Michael H, et al.
Publicado: (2020)

EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry
por: Schmidt, Boris, et al.
Publicado: (2023)

Clinical experience with daptomycin in Europe: the first 2.5 years
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2011)

Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy
por: Xu, Xiaoying, et al.
Publicado: (2016)

Gray matter covariations and core symptoms of autism: the EU-AIMS Longitudinal European Autism Project
por: Mei, Ting, et al.
Publicado: (2020)

European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy
por: Ekman, Bertil, et al.
Publicado: (2014)

Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant Staphylococcus aureus Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid
por: Wright, Bradley M., et al.
Publicado: (2011)

An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection
por: Kauf, Teresa L., et al.
Publicado: (2015)

Daptomycin-Related Rhabdomyolysis Complicated by Severe Hyperkalemia and Acute Kidney Injury
por: Nishimura, Yoshito
Publicado: (2022)

Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus
por: Storm, Jeremy C, et al.
Publicado: (2012)

Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin
por: Jiang, Jhih-Hang, et al.
Publicado: (2015)

Chemoenzymatic synthesis of daptomycin analogs active against daptomycin-resistant strains
por: Scull, Erin M., et al.
Publicado: (2020)

The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg)
por: Caldas, María, et al.
Publicado: (2021)

The Elusive Legitimacy of EU Soft Law: An Analysis of Consultation and Participation in the Process of Adopting COVID-19 Soft Law in the EU
por: ELIANTONIO, Mariolina, et al.
Publicado: (2021)

Stiff skin, soft core: soft backings enhance the conformability and friction of fibre-reinforced adhesives
por: Glaser, Niels C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9c42a4d2l57tqdsvb14h044idp